Ewing's sarcoma - A clinical enigma coming into focus

Journal of Pediatric Hematology/Oncology

Volumn 20, Issue 5, 1998, Pages 421-425

  Denny, Christopher T ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER GENETICS; CHROMOSOME TRANSLOCATION; EWING SARCOMA; GENETIC TRANSCRIPTION; HUMAN; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH;

ADOLESCENT; ADULT; BONE NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 22; GENE REARRANGEMENT; HUMANS; SARCOMA, EWING'S;

EID: 0032464010     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-199809000-00002     Document Type: Review

References (64)

1. Triche TJ, Askin FB, Kissane JM. Neuroblastoma, Ewing's sarcoma, and the differential diagnosis of small-, round-, blue-cell tumors. In: Feingold M, Benningtion JC, eds. Major problems in pathology. Vol 18. Philadelphia. PA: W.B. Saunders, 1987:145-95.
2. Cavazzana AO, Ninfo V, Roberts J, et al. Peripheral neuroepithelioma: a light microscopic, immunocytochemical, and ultrastructural study. Mod Pathol 1992;5:71-8.
3. Kovar K, Dworzak M, Strehl S, et al. Overexpression of the pseudoautosomal gene MIC2 in Ewing's sarcoma and peripheral primitive neuroectodermal tumor. Oncogene 1990;5:1067-70.
4. Perlman EJ, Dickman PS, Askin FB, et al. Ewing's sarcoma - routine diagnostic utilization of MIC2 analysis: a Pediatric Oncology Group/Children's Cancer Group Intergroup Study. Hum Pathol 1994;25:304-7.
5. Thiele CJ. Pediatric peripheral neurectodermal tumors, oncogenes and differentiation. Cancer Invest 1990;8:629-39.
6. Tsokos M, Linnoila RI, Chandra RS, et al. Neuron-specific enolase in the diagnosis of neuroblastoma and other small, round-cell tumors in children. Hum Pathol 1983;15:575-84.
7. Cavazzana AO, Miser JS, Jefferson J, et al. Experimental evidence for a neural origin of Ewing's sarcoma of bone. Am J Pathol 1987;127:507-18.
8. O'Regan S, Diebler MF, Meunier FM, et al. A Ewing's sarcoma cell line showing some, but not all, of the traits of a cholinergic neuron. J Neurochem 1995;64:69-76.
9. Pagani A, Fischer-Colbrie R, Eder U. et al. Neural and mesenchymal differentiations in Ewing's sarcoma cell lines. Morphological, immunophenotypic, molecular biological and cytogenetic evidence. Int J Cancer 1995;63:738-43.
10. Kodama K, Doi O, Higashiyama M, et al. Differentiation of a Ewing's sarcoma cell line towards neural and mesenchymal cell lineages. Jpn J Cancer Res 1994;85:335-8.
11. Turc-Carel C, Aurias A, Mugneret F, et al. Chromosomes in Ewing's sarcoma: I. An evaluation of 85 cases demonstrates remarkable consistency of t(11;22)(q24;q12). Cancer Genet Cytogenet 1988;32:229-38.
12. Whang-Peng J, Triche TJ, Knutsen T, et al. Cytogenetic characterization of selected small round cell tumors of childhood. Cancer Gene Cytogenet 1986;21:185-208.
13. Delattre O, Zucman J, Plougastel B, et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 1992;359:162-5.
14. Ben-David Y, Giddens EB, Letwin K, et al. Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. Genes Dev 1991;5:908-18.
15. Watson DK, Smyth FE, Thompson DM, et al. The ERGB/Fli-1 gene: isolation and characterization of a new member of the family of human ETS transcription factors. Cell Growth Diff 1992;3:705-13.
16. Howard JC, Yousefi S, Cheong G, et al. Temporal order and functional analysis of mutations within the Fli-1 and p53 genes during the erythroleukemias induced by F-MuLV. Oncogene 1993;8:2721-9.
17. Bertolotti A, Lutz Y, Heard DJ, et al. hTAF(II)68, a novel RNA/ssDNA-binding protein with homology to the pro-oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA polymerase II. EMBO J 1996;15:5022-31.
18. Ohno T, Ouchida M, Lee L, et al. The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts and desmoplastic samll round cell tumors, codes for an RNA binding protein with novel regulatory domains. Oncogene 1994;9:3087-97.
19. Crozat A, Aman P, Mandahl N, et al. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 1993;363:640-4
20. Rabbitts TH, Forster A, Larson R, et al. Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nat Genet 1993;4:175-80.
21. Downing JR, Head DR, Parham DM, et al. Detection of the (11;22)(q24;q12) translocation of Ewing's sarcoma and peripheral neuroectodermal tumor by reverse transcription polymerase chain reaction. Am J Pathol 1993;143:1294-300.
22. Sorensen PHB, Liu XF, Delattre O, et al. Reverse transcriptase PCR amplification of EWS/FLI-1 fusion transcripts as a diagnostic test for peripheral primitive neuroectodermal tumor of childhood. Diagn Mol Pathol 1993;2:147-57.
23. Zucman J, Melot T, Desmaze C, et al. Combinatorial generation of variable fusion proteins in Ewing family tumors. EMBO J 1993;12:4481-7.
24. Desmaze C, Brizard F, Turc-Carel C, et al. Multiple chromosomal mechanisms generate an EWS/FLI1 or an EWS/ERG fusion gene in Ewing tumors. Cancer Genet Cytogenet 1997;97:12-9.
25. Whang-Peng J, Freter CE, Knutsen T, et al. Translocation t(11;22) in esthesioneuroblastoma. Cancer Genet Cytogenet 1987;29:155-7.
26. Sorensen PH, Wu JK, Berean KW, et al. Olfactory neuroblastoma is a peripheral primitive neuroectodermal tumor related to Ewing sarcoma. Proc Natl Acad Sci USA 1996;93:1038-43.
27. Sorensen PH, Shimada H, Liu XF, et al. Biphenotypic sarcomas with myogenic and neural differentiation express the Ewing's sarcoma EWS/FLI1 fusion gene. Cancer Res 1995;55:1385-92.
28. Thorner P, Squire J, Chilton-MacNeil S, et al. Is the EWS/FLI-1 fusion transcript specific for Ewing sarcoma and peripheral primitive neuroectodermal tumor? A report of four cases showing this transcript in a wider range of tumor types. Am J Pathol 1996;148:1125-38.
29. Burchill SA, Wheeldon J, Cullinane C, et al. EWS-FLIl fusion transcripts identified in patients with typical neuroblastoma. Eur J Cancer 1997;33:239-43.
30. May WA, Gishizky ML, Lessnick SL, et al. Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. Proc Natl Acad Sci USA 1993;90:5752-6.
31. Kovar H, Aryee DN, Jug G, et al. EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro. Cell Growth Diff 1996;7:429-37.
32. Ouchida M, Ohno T, Fujimura Y, et al. Loss of tumorigenicity of Ewing's sarcoma cells expressing antisense RNA to EWS-fusion transcripts. Oncogene 1995;11:1049-54.
33. Tanaka K, Iwakuma T, Harimaya K, et al. EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells. J Clin Invest 1997;99:239-47.
34. Toretsky JA, Connell Y, Neckers L, et al. Inhibition of EWS-FLI-1 fusion protein with antisense oligodeoxynucleotides. J Neuro-Oncol 1997;31:9-16.
35. Lessnick SL, Braun BS, Denny CT, et al. Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI fusion gene. Oncogene 1995;10:423-31.
36. Zucman J, Melot T, Desmaze C, et al. Combinatorial generation of variable fusion proteins in the Ewing family of tumors. EMBO J 1993;12:4481-7.
37. May WA, Lessnick SL, Braun BS, et al. The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1. Mol Cell Biol 1993;13:7393-8.
38. Bailly RA, Bosselut R, Zucman J, et al. DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma. Mol Cell Biol 1994;14:3230-41.
39. Mao X, Miesfeldt S, Yang H, et al. The FLI-1 and chimeric EWS-FLI-1 oncoproteins display similar DNA binding specificities. J Biol Chem 1994;269:18216-22.
40. Ohno T, Rao VN, Reddy ES. EWS/Fli-1 chimeric protein is a transcriptional activator. Cancer Res 1993;53:5859-63.
41. Braun BS, Freiden R, Lessnick SL, et al. Identification of target genes to the Ewing's sarcoma EWS/FLI fusion protein by Representational Difference Analysis. Mol Cell Biol 1995;15:4623-30.
42. McDonnell S, Matrisian LM. Stromelysin in tumor progression and metastasis. Cancer Metastasis Rev 1990;9:305-19.
43. Matrisian LM. Metalloproteinases and their inhibitors in matrix remodeling. Trends in Genetics 1990;6:121-5.
44. Thompson AD, Braun BS, Arvand A, et al. EAT-2 is a novel SH2 domain containing protein that is up regulated by Ewing's sarcoma EWS/FLI1 fusion gene. Oncogene. 1996;13:2649-58.
45. Townsley FM, Aristarkhov A, Beck S, et al. Dominant-negative cyclin-selective ubiquitin carrier protein E2-C/UbcH10 blocks cells in metaphase. Proc Natl Acad Sci USA 1997;94:2362-7.
46. Arvand A, Bastians H, Welford SW, et al. EWS/FLI1 up regulates mE2-C, a cyclin-selective ubiquitin conjugating enzyme involved in cyclin B destruction. Oncogene. In press.
47. Johnston SH, Rauskolb C, Wilson R, et al. A family of mammalian Fringe genes implicated in boundary determination and the Notch pathway. Development 1997;124:2245-54.
48. May WA, Arvand A, Thompson AD, et al. EWS/FLI1-induced Manic Fringe renders NIH 3T3 cells tumorigenic. Nat Genet 1997;17:495-7.
49. Lee CS, Southey MC, Waters K, et al. EWS/FLI-1 fusion transcript detection and MIC2 immunohistochemical staining in the diagnosis of Ewing's sarcoma. Pediatr Pathol Lab Med 1996;16:379-92.
50. Scotlandi K, Serra M, Manara MC, et al. Immunostaining of the p30/32MIC2 antigen and molecular detection of EWS rearrangements for the diagnosis of Ewing's sarcoma and peripheral neuroectodermal tumor. Hum Pathol 1996;27:408-16.
51. Pfleiderer C, Zoubek A, Gruber B, et al. Detection of tumour cells in peripheral blood and bone marrow from Ewing tumour patients by RT-PCR. Int J Cancer 1995;64:135-9.
52. West DC, Grier HE, Swallow MM, et al. Detection of circulating tumor cells in patients with Ewing's sarcoma and peripheral primitive neuroectodermal tumor. J Clin Oncol 1997;15:583-8.
53. Sorensen PHB, Lessnick SL, Lopez-Terrada D, et al. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG. Nat Genet 1994;6:146-51.
54. Jeon I-S, Davis N, Braun BS, et al. The variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. Oncogene 1995;10:1229-34.
55. Peter M, Couturier J, Pacquement H, et al. A new member of the ETS family fused to EWS in Ewing tumors. Oncogene 1997;14:1159-64.
56. Kaneko Y, Yoshida K, Handa M, et al. Fusion of an ETS-family gene, EIAF, to EWS by t(17;22)(q12;q12) chromosome translocation in an undifferentiated sarcoma of infancy. Genes Chromosomes Cancer 1996;15:115-21.
57. Urano F, Umezawa A, Hong W, et al. A novel chimera gene between EWS and E1A-F, encoding the adenovirus E1A enhancer-binding protein, in extraosseous Ewing's sarcoma. Bioch Biophys Res Com 1996;219:608-12.
58. Panagopoulos I, Hoglund M, Mertens F, et al. Fusion of the EWS and CHOP genes in myxoid liposarcoma. Oncogene 1996;12:489-94.
59. Labelle Y, Zucman J, Stenman G, et al. Oncogenic conversion of a novel orphan nuclear receptor by chromosome translocation. Hum Mol Genet 1995;4:2219-26.
60. Clark J, Benjamin H, Gill S, et al. Fusion of the EWS gene to CHN, a member of the steroid/thyroid receptor gene superfamily, in a human myxoid chondrosarcoma. Oncogene 1996;12:229-35.
61. Brody RI, Ueda T, Hamelin A, et al. Molecular analysis of the fusion of EWS to an orphan nuclear receptor gene in extraskeletal myxoid chondrosarcoma. Am J Pathol 1997;150:1049-58.
62. Zucman J, Delattre O, Desmaze C, et al. EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nat Genet 1993;4:341-5.
63. Ladanyi M, Gerald W. Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor. Cancer Res 1994;54:2837-40.
64. Rauscher FJ 3rd, Benjamin LE, Fredericks WJ, et al. Novel oncogenic mutations in the WT1 Wilms' tumor suppressor gene: a t(11;22) fuses the Ewing's sarcoma gene, EWS1, to WT1 in desmoplastic small round cell tumor. Cold Spring Harbor Symp Quant Biol 1994;59:137-46.